C. Michael White

C. Michael White is a Professor at the University of Connecticut School of Pharmacy, Department of Pharmacy Practice. With a Pharm.D. and over 500 peer-reviewed publications, he specializes in clinical pharmacology, drug safety, and healthcare policy. His research focuses on preventing adverse drug events, dietary supplement risks, and regulatory oversight gaps in pharmaceuticals.

• Established AFIST regimen for post-cardiothoracic surgery atrial fibrillation
• Defined magnesium's role in Torsade de Pointes prevention
• Provided evidence for FDA's ephedra ban
• Advocated for better FDA oversight of drugs and supplements

Research Interests: Comparative effectiveness analysis, drug-induced disease prevention, substance abuse pharmacology, and healthcare system sustainability. His work spans from psychedelic therapies for mental health to critical evaluations of pharmaceutical quality and regulatory frameworks.

Scientific Awards: ACCP Young Investigator of the Year, AACP Lyman Award, six-time ASHP Foundation Drug Therapy Research Award recipient, and lifetime achievement ASHP Award for Sustained Contributions to the Literature.

Public Engagement: Featured in major media outlets (NBC, CNN, NY Times), led Connecticut's vaccine training during COVID-19, and chairs the national Kratom Consumer Advisory Council. He received UConn's Provost's Award for Public Engagement (2014, 2021) and the Hartford Business Journal's Healthcare Hero Award (2021).